EP 4337259 A1 20240320 - COMPOUNDS FOR DEGRADING ALPHA-SYNUCLEIN AGGREGATES AND USES THEREOF
Title (en)
COMPOUNDS FOR DEGRADING ALPHA-SYNUCLEIN AGGREGATES AND USES THEREOF
Title (de)
VERBINDUNGEN ZUM ABBAU VON ALPHA-SYNUCLEINAGGREGATEN UND VERWENDUNGEN DAVON
Title (fr)
COMPOSÉS POUR LA DÉGRADATION D'AGRÉGATS D'ALPHA-SYNUCLÉINE ET LEURS UTILISATIONS
Publication
Application
Priority
IB 2021054167 W 20210514
Abstract (en)
[origin: WO2022238737A1] The present disclosure provides compounds comprising an E3 ubiquitin ligase binding moiety and an alpha-synuclein protein binding moiety for use in the treatment of neurodegenerative diseases, in particular synucleinopathies.
IPC 8 full level
A61K 47/55 (2017.01); A61P 25/28 (2006.01); C07D 417/14 (2006.01)
CPC (source: EP KR)
A61K 31/4439 (2013.01 - KR); A61K 31/454 (2013.01 - KR); A61K 47/545 (2017.08 - EP KR); A61K 47/55 (2017.08 - EP KR); A61P 25/28 (2018.01 - EP KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2022238737 A1 20221117; AU 2021444937 A1 20231130; CA 3218573 A1 20221117; CN 117377496 A 20240109; EP 4337259 A1 20240320; JP 2024517340 A 20240419; KR 20240008335 A 20240118; TW 202304516 A 20230201
DOCDB simple family (application)
IB 2021054167 W 20210514; AU 2021444937 A 20210514; CA 3218573 A 20210514; CN 202180098221 A 20210514; EP 21726997 A 20210514; JP 2023570190 A 20210514; KR 20237042637 A 20210514; TW 111118050 A 20220513